# Vivos Therapeutics, Inc.: Form 8-K, filed Dec 23, 2024

- Company: [Vivos Therapeutics, Inc.](/companies/vvos.md) (CIK 1716166)
- Form: 8-K
- Filed: 2024-12-23
- Accepted by EDGAR: Dec 23, 2024, 17:29 ET
- Period: 2024-12-23
- Accession: 0001493152-24-051890
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/form8-k.htm

Filed Dec 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-051890. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.